Entry of blood-borne pathogens into the spleen elicits a series of changes in cellular architecture that culminates in the systemic release of protective antibodies. Despite an abundance of work that has characterized these processes, the regulatory mechanisms that coordinate cell trafficking and antibody production are still poorly understood. Here, marginal zone (MZ) B cells responding to streptococcus in the blood were observed to migrate along splenic nerves, arriving at the red pulp venous sinuses where they become antibody-secreting cells. Electrical stimulation of the vagus nerve, which in turn regulates the splenic nerve, arrested B-cell migration and decreased antibody secretion. Thus, neural circuits regulate the first wave of antibody production following B-cell exposure to blood-borne antigen.
INTRODUCTION
Pneumococcal (PC) disease is second only to influenza as the most common cause of vaccine-preventable death in the United States. The humoral response to blood-borne Streptococcus pneumoniae is a T cell-independent response that occurs almost exclusively in the spleen. Phosphorylcholine, the immunodominant antigenic epitope in pneumococcal polysaccharide, elicits B-cell production of anti-PC antibodies required for protective immunity (1) . During pneumococcal invasion, neutrophils, monocytes and dendritic cells (DC) capture and transport the bacteria to the spleen, where resident antigen-specific marginal zone B cells (MZB) and B1 cells are activated (2, 3, 4) . These activated B cells differentiate into antibody-secreting cells, a process that involves the reexpression of syndecan-1 (CD138) and the downregulation of adhesion molecules (5, 6) . Finally, the antibody-secreting cells migrate along reticular fibers to the red pulp (RP) (7) , where they release antibodies into the blood (8, 9) . MZ and B1 B cells have a preactivated phenotype and express membrane immunoglobulins mainly of the immunoglobulin M (IgM) isotype (10) ; thus, they can initiate a rapid antibody response to bacterial polysaccharide which is detectable in the serum as early as 48 h after infection (8) . These critical steps underlying B-cell activation and migration are key to efficient secretion of antibodies, which is necessary to confer significant protection against life-threatening infections from encapsulated bacteria (11) . Disruption of these mechanisms, as occurs in splenectomized individuals, young children, the elderly and in transgenic animals lacking the chemokines or integrins that participate in the activation and migration of MZ cells, are associated with significant morbidity and mortality (12) (13) (14) (15) .
Importantly, the strongest independent risk factor for invasive pneumococcal disease (IPD) among immunocompetent adults is cigarette smoking (16) . Smokers account for approximately half of otherwise healthy adult patients with invasive pneumococcal disease and exhibit antibody titers to pneumococcal vaccination that are attenuated by 20% to 30% (17) . Cigarette smoking alters mucociliary clearance, which increases adherence of bacteria, disrupts epithelium and alters nasopharyngeal colonization (18, 19) . These factors are not sufficient, however, to explain the increased risk for invasive disease. Accordingly, it has been suggested that other mechanisms likely play a significant role in increasing the risk of IPD in smokers (17, 20) .
Cigarette smoke contains nicotine, a cholinergic agonist with strong immunomodulatory capabilities. We and others have demonstrated that nicotine signalNeural Signaling in the Spleen Controls B-Cell Responses to Blood-Borne Antigen ing through the α 7 nicotinic acetylcholine receptor subunit (α7nAChR) stimulates the cholinergic antiinflammatory pathway, a vagus neural circuit that significantly inhibits the release of TNF and other cytokines in the spleen (21) . Electrical stimulation of the vagus nerve or splenic nerve downregulates cytokine production in the spleen in acute and chronic models of systemic inflammation (22, 23) . Moreover, cholinergic and adrenergic neurotransmitters modulate B-cell function by interacting with specific neurotransmitter receptors that modulate B-cell activation and migration responses (24, 25) . Accordingly, we reasoned that neural signals mediated through the α7nAChR may diminish the antibody response to PC. The data presented show that vagus nerve stimulation or administration of nicotine significantly diminished the initial antibody response against heat-killed pneumococcus, to a degree quantitatively similar to that observed in human smokers, by a mechanism that arrests B-cell migration in the MZ.
MATERIALS AND METHODS

Mice
Female 6-to 8-wk-old Balb/C from Jackson Laboratories (Bar Harbor, ME, USA) were housed under pathogen-free conditions. Mice were injected intraperitoneally (i.p.) with 1 mg/kg of nicotine SigmaAldrich, St. Louis, MO, USA) or 40 mg/kg of 3-[(2,4-dimethoxy) benzylidene]-anabaseine dihydrochloride (DMXBA; GTS-21) (26) as a single injection or daily for up to 17 d. In some experiments, animals received a 1 mg/kg i.p. injection of mecamylamine hydro chloride (SigmaAldrich) 20 min before injections of nicotine.
Bacteria and Immunization/Infection
Streptococcus pneumonia strains R363 or ATCC 6303 were grown and inactivated as described previously (27) . Briefly, R363 bacteria were grown to log phase in Todd Hewitt media containing 0.5% yeast extract and blood agar for 24 h at 3°C. Serotype 3 ATCC 6303 strain bacteria were grown in Trypticase soy agar with 5% defibrinated sheep blood or brain heart infusion (BD, Franklin Lakes, NJ, USA) in a 5% CO 2 atmosphere. Subsequently, the bacteria were pelleted, heat killed in phosphate buffered saline (PBS) at 56°C for 45 min and further digested in a 0.2% pepsin solution for 2 h at 37°C. The pH was neutralized with 1N NaOH. The cells were washed with PBS and the concentration was determined by measuring the optical density: 1 O.D. = 2 × 10 8 colony forming units (CFU)/mL. Bacteria stocks were kept at -20°C until use. Mice were injected intravenously (i.v.) (retro-orbital) with a suspension of 1 × 10 9 CFU/animal in 100 µL of saline and euthanized 15 min to 17 d after the bacterial challenge. For live bacteria injections, pneumococcus were injected at an approximate concentration of 1 × 10 5 CFU/ mouse as described previously (28) . Mice were euthanized 15 min after the injection.
Enzyme-Linked Immunosorbent Assay (ELISA)
PC-specific antibody titers were measured by adding serum samples to plates coated with phosphorylcholineconjugated keyhole limpet hemocyanin (PC-KLH) 10 µg/mL in PBS overnight at 4°C. Selected serum samples were calibrated using mouse IgM of known concentration as a standard to determine the antibody concentration in µg/mL relatively, and these samples were utilized as reference in all subsequent experiments. ELISAs were performed using a 1:1000 dilution of an alkaline phosphatase (AP)-conjugated antimouse IgM antibody. Endpoint readings were performed using a Victor spectrophotometer (EGG-Wallac). µg/mL in PBS overnight at 4°C, washed with PBS/0.1% Tween-20 and blocked with RPMI containing 10% fetal bovine serum (FBS) for 1 h at 37°C. Cells were incubated overnight at 37°C. After washing with PBS/0.1% Tween-20, 100 µL/well of a 1:100 dilution of an AP-conjugated goat anti-mouse IgM were added to each well and incubated for 1 h at 37°C. The plates were washed and developed using a 1 mg/mL solution of 5-bromo-4-chloro-3-indolyl phosphate disodium salt (5-BCIP) in filtered AMP buffer 0.203 g MgCl2.6H20, 0.1 mL Triton-X 405, 95.8 mL 2-amino-2-methyl-1-propanol (AMP), (pH 9.8). High resolution pictures of the plates were obtained with a digital camera and quantification of TIFF pictures was performed using the colony counting function of the Quantity One software (Bio-Rad, Hercules, CA, USA).
Flow Cytometry
Total splenocytes were incubated with the following anti-mouse antibodies: CD19 and Gr-1 (eBioscience, San Diego, CA, USA), B220-PerCP and CXCR4-AF647 (Biolegend, San Diego, CA, USA), CD138-PE, CD11b-PE, Ly6G-FITC, IgM-APC (BD Biosciences, San Diego, CA, USA), CD49d-FITC (Abcam, Cambridge, MA, USA). FcR binding was prevented by incubating with a 1:500 dilution of the 2.4G2 antibodies. Analysis was performed using an LSR-II flow cytometer (BD Biosciences).
Electrical Stimulation of the Vagus Nerve
Mice were anesthetized with 100 mg/ kg ketamine and 10 mg/kg xylazine intramuscular (i.m.). Vagus nerve stimulation was performed during 2.5 min as described previously. Briefly, electrical stimulation (1 V, 2 ms, 5 Hz) was performed using a stimulation module (STM100A) under the control of the AcqKnowledge software (Biopac Systems, Goleta, CA, USA) through a bipolar platinum electrode (Plastics One, Roanoke, VA, USA) laced across the isolated left cervical vagus nerve. Immediately after nerve stimulation, mice were immunized as indicated above, with 1 × 10 9 CFU/mouse in 100 µL of saline and euthanized 15 min later. Control mice were subjected to sham surgery in which the vagus nerve was exposed, but not manipulated.
Chemical Ablation of Catecholaminergic Nerves
6-hydroxydopamine (6-OHDA) (Sigma-Aldrich) in 0.9% NaCl containing 0.1% ascorbic acid (Sigma-Aldrich) was administered intraperitoneally on d -7 (100 µg/kg), -5 and -3 (200 µg/kg) before immunization. Control animals were injected with 0.1% ascorbic acid in 0.9% NaCl. Catecholamine depletion was confirmed by histofluorescence using the sucrose-phosphate-glycoxylic acid method as described previously (29) .
Surgical Ablation of the Splenic Nerve
Mice were anesthetized with 2% isoflurane and a left lateral abdominal incision was performed. The branches of the splenic nerve, which travel along the splenic artery, were isolated and dissected using forceps. The splenic nerve was transected along the branches of the splenic artery close to the spleen hilum. Finally, the abdominal wall was closed and the immunization procedure was performed as described above 7 d after the surgical procedure, which is the time required for complete degeneration of splenic nerve endings.
Immunohistochemistry
Frozen spleen sections mounted on glass slides were fixed in acetone, rehydrated in PBS and incubated with a 1:500 dilution of an unlabeled anti-FcR antibody in PBS/0.5% BSA for 30 min. Subsequently, the sections were incubated for 1 h at room temperature with the following antibodies at a 1:100 dilution in PBS: synaptophysin, retinaldehyde dehydrogenase (RALDH), CD49d (Abcam), CD138-PE, CD1d-PE, CD31-PE, CD11c-PB and MOMA-1-FITC (BD Biosciences), B220-Pacific blue (eBioscience), specific intracellular adhesion molecule-grabbing nonintegrin receptor 1 (SIGN-R1)-biotin (Novus Biologicals, Littleton, CO, USA), laminin (Sigma-Aldrich), fibronectin-biotin (Rockland Immunochemicals, Gilbertsville, PA, USA). Slides were washed and mounted using Dako fluorescent mounting media (Dako, Carpinteria, CA, USA) and imaged using a Hamamatsu ORCA + ER digital camera attached to an Axioplan2 Zeiss upright fluorescence microscope. Image acquisition and analysis was performed using the Openlab 4.0.4 software. 
Dextran Injections
Mice were injected i.v. with a solution of 1 mg/mL of FITC-conjugated 40S-Dextran (Sigma-Aldrich) along with heat-killed pneumococcus as described above, 5 min after an i.p. injection of saline or 1 mg/kg of nicotine. Mice were euthanized 1 h after injection and the spleens dissected and processed for immunohistochemistry as before.
All supplementary materials are available online at www.molmed.org.
RESULTS
Nicotine Impairs Humoral Immune Responses Via the Vagus and Splenic Nerves
It has been demonstrated clearly that vagus nerve stimulation can modulate aspects of the innate immune response. T-independent B-cell responses constitute the humoral arm of the innate response, as they occur quickly after antigen exposure and do not lead to memory cell formation. To address the question of whether neural signals alter the humoral immune response in vivo, we explored the T-independent response to intravenous heat-killed Streptococcus pneumoniae after administration of nicotine, a cholinergic agonist. Mice were injected i.p. with a daily dose of 1 mg/kg of nicotine or saline as a control, starting 1 d before exposure to Streptococcus pneumoniae (10 9 CFU/mouse) and continuing daily for up to 17 d. Nicotine injection resulted in a 49.5% reduction in the number of anti-PC antibody secreting cells in spleens as determined by ELISpot assay on d 6 after immunization ( Figure 1A ). We observed significantly lower serum antibody titers at d 3 and d 6 after immunization in animals receiving nicotine compared with saline controls (Figures 1B-C) . Although less pronounced, a decrease in antibody titers was observed with doses of nicotine as low as 400 µg/ mL (not shown).
Nicotine is a relatively nonselective agonist for the larger class of nicotinic acetylcholine receptors. To confirm the specific role of α7nAChR, we next utilized 1B ). Further, administration of the nicotinic receptor antagonist mecamylamine 20 min prior to nicotine dosing (see Figure 1C ) significantly reversed the effect of nicotine on antibody production. Together, these results indicate that nicotinic signaling modulates innate antibody responses through α7nACh.
The cholinergic antiinflammatory pathway is a two neuron circuit (30) . Action potentials originating in the vagus nerve propagate to and terminate at the celiac ganglion, where the cell bodies of the postganglionic secondary neurons reside. These give rise to the splenic nerve, the only nerve to the spleen, which is adrenergic (31) . To determine the participation of the adrenergic splenic neurons in modulating the antibody response to pneumococcus, we exposed mice to three doses of 6-hydroxydopamine (6-OHDA), to chemically ablate splenic adrenergic neurons. Injections were given 48 h apart on d -7, -5 and -3 before administration of pneumococcus on d 0. The effectiveness of adrenergic neuronal ablation was established by histofluorescence (Supplementary Figure 1 ). Chemical ablation of splenic nerves decreased antibody titers significantly, an observation that was expected from previous work showing that adrenergic signaling maintains the integrity of an antibody response (31) . Importantly, chemical splenic nerve ablation reversed the effect of nicotine on inhibiting antibody levels significantly, confirming that the cholinergic antiinflammatory pathway inhibits the antibody responses to PC ( Figure 1D ).
Cholinergic Stimulation Induces Accumulation of Cells in the MZ at Early Time Points
To understand the mechanism by which neural signals regulate the antipneumococcal antibody response, we studied early trafficking, distribution and adhesion molecule expression of leukocytes participating in the activation of B cells. Spleen sections were prepared from tissue obtained 15 min to 4 h after nicotine injection and antigen challenge. MZB are known to be retained in the MZ by adhesion of the integrins leukocytefunction adhesion molecule-1 (LFA-1), a member of the β2 family and α4β1 very late antigen-4; (VLA-4) to intracellularadhesion molecule-1 (ICAM-1) and vascular cell-adhesion molecule-1 (VCAM-1), respectively 6). In contrast, B1b cells, monocytes and neutrophils express the αMβ2 integrin ITGAM, CD11b, (Mac-1). As is the case with other leukocytes, activated MZB need to downregulate these integrins to exit the MZ (6).
Cells expressing CD49d, the α-4 subunit of VLA-4, were distributed sparsely in the RP and the outer MZ of spleens from nonimmunized mice. CD11b, the polysaccharide receptor SIGN-R1 (Figure 2F) . To confirm this observation, FITC-labeled dextran, which is phagocytized by SIGN-R1 + MZM, was administered to mice 1 h before nicotine or saline injection and antigen challenge. As shown in Figure 2G , green fluorescently labeled cells that had ingested dextran were distinct from CD11b + cells confirming that MZM differ from these CD11b + cells (Supplementary Figures 2C, D) . Gr1 Figure 3B ) although the mean fluorescence intensity was not changed significantly. Histological analysis also demonstrated that the colocalization of CD11b and Gr1 seen on histology frequently in the MZ and rarely in the RP ( Figure 2H arrows) was not due to coexpression of both markers, but rather to the two cell types present in close contact (see Supplementary Figure 3B) .
We wished to determine if the response to live bacteria was subject to the same regulatory mechanisms that we observed in the response to heat killed bacteria. Mice that had been injected i.v. with a live virulent strain of Streptococcus pneumoniae (strain ATCC 6303) or with the same pneumococcal strain (R363) without inactivation also exhibited migratory arrest following nicotine administration. Gr1 most follicles in nicotine-treated mice, but rarely in saline-treated mice (Supplementary Figure 4) . Thus, the response to heat-killed and live organisms was comparable.
Kinetics of the Migratory Arrest
Histologic analysis suggested that the migratory arrest of B cells in the MZ, and the concomitant arrest of other leukocytes involved in their activation, might be responsible for lower numbers of activated antibody-secreting cells (ASCs) in the RP and the decreased antibody titers. We found that the lymphoid reorganization that occurs after streptococcal challenge was transient and started to disappear at approximately 4 h after nicotine and antigen injection ( Figure 3A) and was absent at the time of peak antibody titers in the serum (Fig ures 3B, D) (6) in mice receiving a single dose of nicotine. In contrast, numerous CD11b + cells remained accumulated in the MZ and perifollicular areas of mice receiving a daily dose of nicotine or GTS-21 even at 6 d after immunization (Fig ure 3C) . Ly6G + neutrophils, on the other hand, appeared similarly distributed in the RP in both control and stimulated mice at this time point (see Figure 3C ).
The MZ Migratory Arrest Is Controlled by the Cholinergic Antiinflammatory Pathway
To demonstrate directly the neural mechanism for regulating migratory arrest, we next assessed cell trafficking following direct electrical stimulation of the vagus nerve, using methods that we have developed and described previously (30) . We observed that vagus nerve stimulation arrested the transit of cells from the MZ significantly ( Figures 4A-B) . To track the anatomic basis of this neural circuit, we next performed selective surgical splenic neurectomy to denervate the spleen (30) . Mice subjected to neurectomy or sham surgery were immunized 8 d later, and nicotine or saline was injected 1 d before and at the time of antigen exposure, as before. As expected CD11b Figure 4D SNVX,  arrow) . Together with the data that nicotine stimulates splenic nerve signals to suppress antibody titers, these results suggest that neutrally controlled expression of CD11b is a major mechanism for the retention of MZB cells and other leukocytes in the MZ. Splenic denervation downregulated CD11b expression significantly even in the absence of cholinergic stimulation ( Figure 4D and Supplementary Figure 5 ) confirming previous reports of a tonic role for the splenic nerve in adhesion molecule expression (34) and demonstrating a connection between migration arrest and reduced antibody titers.
CD138 + Plasma Cells Are Associated with Nerve Fibers in the Spleen
Upon activation, MZB migrate toward the RP where they release antibodies to the blood. We therefore investigated the localization of nerve fibers to determine whether associations with ASCs (CD138 + ) could modulate their secretory capabilities as had been demonstrated previously (in vitro) as an additional mechanism to explain the effect of cholinergic stimulation on the antibody response. Mice were euthanized 2 to 6 d after immunization. As expected, we observed that nerve fibers in the subcapsular plexus followed the trabeculae around venous sinuses and in vascular plexuses associated with branches of the splenic artery. These follow the central arteries to the white pulp where nerve endings radiate from the perivascular nerve into the T-cell dense regions. Innervation of B-cell follicles is sparse, but nerve fibers are present along the parafollicular zones, mainly in splenic cords and, less frequently, in the marginal sinus and MZ. Few CD138 + cells were present in mice without bacterial challenge. As expected, after antigen challenge CD138 + cells were found primarily in the RP (Figures 5A, B) , Interestingly, most CD138 + in extrafollicular areas were found to be associated with synaptophysin-positive structures localized along reticular fibers of the splenic cords and trabeculae, as well as in the immediate vicinity of venous sinuses of the RP which are also innervated (Figures 5C-D) . Importantly, not all reticular fibers in the splenic cords were adjacent to CD138 + cells; rather, the association coincided with regions of innervation, as has been shown in other organs (35) .
CD138
+ Cells Are Antigen-Specific ASCs
We next determined that the CD138 + cells, which localized adjacent to the nerves were antigen-specific ASCs. CD138 + cells expressed immunoglobulin as determined by κ-light-chain staining ( Figure 5E ) and were seldom detectable in spleens of nonimmunized mice (Figure 5F ). We performed ELISpot assays on B cells obtained at d 6 after immunization. ASCs were localized either near venous sinuses or aligned along laminin and fibronectin-containing fibrous structures that run along the reticular network of the splenic cords and the trabeculae (Figures 6B-D) . Fibrous structures that had IgM + cells associated with them were innervated. The characteristic varicose configuration of nerves was found alongside the strands of fibronectin (Figures 6E-F) . These structures were only occasionally associated with vascular elements (Supplementary Figure 6) . This finding suggests that migrating lymphocytes, as well as those in contact with the vasculature for antibody secretion, are in close contact with splenic neurons that can exert a regulatory influence on the activation of MZB cells.
DISCUSSION
In the present work, we provide evidence that neural signals can diminish the antibody response to Streptococcus pneumoniae. This is mediated by signaling through the cholinergic antiinflammatory pathway, and can be replicated using specific α7nAChR agonists or direct electrical stimulation of neurons. Moreover, pharmacological antagonists, and chemical or surgical ablation of the pathway restore antibody titers to normal levels in animals exposed to nicotine. The effect is evident as soon as specific antibodies start to be detected in the blood of immunized animals suggesting an alteration in early steps of the response.
Significant alterations in the splenic architecture were observed early after antigen challenge. We observed a marked accumulation of B cells, neutrophils, monocytes and DC in the MZ of spleens from stimulated compared with control mice. This accumulation is in part explained by the increased influx of cells into the spleen upon cholinergic stimulation as reported recently (34) . However, resident and newly arrived cells were found to remain in the MZ of stimulated mice at time points at which the majority of cells were already in the RP and perifollicular areas in control animals. The phenomenon was demonstrated to be under neural control because electrical stimulation of the vagus nerve induced migratory arrest, which was abrogated by surgical ablation of the splenic nerve. The arrested cells express the adhesion molecule CD11b and cluster around CD49d + cells. Surgical ablation of the splenic nerve profoundly alters the distribution of CD11b + cells in the spleen, resulting in their accumulation in the RP even in saline-injected animals demonstrating that the homeostatic regulation in the spleen is under neural control as reported previously (34) . Importantly, the arrest of MZ cells occurs in response to both killed bacteria and to live bacteria. This immobilization of ASCs accounts at least in part for the decreased antibody response, though we cannot assess the antibody response in mice given live bacteria, as the bacterial challenge is lethal.
ASCs that have migrated successfully to the RP often are associated with reticular fibers in the RP that are known to guide their migration toward vessels where they secrete antibodies (9) . We found that these conduits are innervated frequently which permits direct exposure of migrating cells to neurotransmitters. This observation demonstrates a second potential mechanism for the regulation of antibody secretion by the nervous system. A physical association between ASCs and nerve fibers has been shown in the intestine where neurotransmitters have been proposed to regulate antibody secretion of ASCs that migrate toward nerve fibers upon activation (35) . Our observations in the spleen are in line with those findings suggesting that nerve signals participate in the regulation of the humoral immune response in several organs by similar mechanisms. The nature of the neurotransmitter released upon vagus nerve stimulation (VNS) in the spleen was not determined directly, but norepinephrine is the predominant neurotransmitter released by splenic nerves (36) and this neurotransmitter is capable of altering B-cell function in vitro (24, 25, 37, 38) .
A recent report demonstrates, in striking similarity to our findings, that immune cells cluster around nerves in developing lymph nodes and that vagus nerve stimulation induces the expression of chemokines via retinoic acid (RA) (39) . RA is a potent inducer of adhesion molecule expression and a regulator of leukocyte trafficking by this mechanism (40, 41) . Our preliminary results suggest that RALDH, the enzyme responsible for the metabolism of vitamin A to RA is expressed in the cells that accumulate in the MZ cells of cholinergically stimulated animals along with adhesion molecules known to be required for their retention in the MZ (6) . Inhibition of this pathway with disulfiram reduces the number of cellular aggregates surrounding the follicles of nicotine-injected immunized animals suggesting a contribution of the RA pathway to the alteration in leukocyte trafficking observed in these animals, and the modulation of RA synthesis by neural input (unpublished data).
Of clinical significance, a 20% to 30% decrease in the antibody titers to pneumococcal immunization, similar to the decrease we observed in nicotine-treated animals has been described in human smokers (17, 42, 43) . Among immunocompetent adults, the strongest independent risk factor for invasive pneumococcal disease (IPD) is cigarette smoking (16) and the Center for Disease Control (CDC) has recommended the pneumococcal vaccine for smokers (44) . Due to the importance of anti-PC antibodies in the protection from pneumococcal infections, our data support a model in which decreased antibody responses due to nicotine stimulation are at least in part responsible for the increased susceptibility of smokers to IPD, and direct damage to the airway by cigarette smoke may be less important than previously thought.
While a single electrical stimulation of the vagus nerve in mice caused migratory arrest, it was not sufficient to alter the antibody titers measured 3 or 6 d after stimulation (not shown). Thus, altered humoral responses require repeated stimulation of the vagus nerve. In humans, however, the effect of tobacco smoke exposure on serum concentration of antibodies, although temporary, persists for several months after cessation of smoking. It is plausible to consider that, for chronic smokers, ongoing exposure to nicotine persistently inhibits cell migration leading to decreased antibody responses.
CONCLUSION
In conclusion, neural signaling regulates the development of humoral immunity by modulating cell trafficking and lymphoid architecture reorganization. It has been shown previously that neural signals control egress of immune cells from the bone marrow (45) . These data extend the paradigm to show that cell mi-gration within secondary lymphoid organs is also controlled by neural signals. Most significantly, antibody secretion is therefore a neurally controlled event.
There are important implications to these data, as it may be possible to modify antibody output to therapeutic advantage by targeting these mechanisms.
